Antisense oligonucleotide mediated knockdown of BRCA2 increased the sensitivity of human lung, ovarian and breast cancer cells to cisplatin and reversed the resistance to cisplatin acquired by head and neck cancer cells. This evidence concerns the gene BRCA2 and head and neck cancer.